Skip to Main Content

Paper Details

Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased <sup>1</sup>H NMR-Linked Metabolomics Strategy.
Cells
4
2021
1H, GM1 Type 2 Gangliosidosis, GM1 gangliosidosis type 2 (GM1T2) disease, GM1T2, GM1T2 disease, GM1T2 disorder, HC, alanine, amino acid, amino acids, amino-sugar, aspartate, blood plasma, branched-chain amino acid, ethanol, fatty acid, fibroblasts, glutathione, human, participants, propanoate, seleno-, triacylglycerols
Author NameAffiliation
Cynthia J TifftDeputy Clinical Director, National Human Genome Research Institute, National Institutes of Health
Cynthia J TifftDeputy Clinical Director, National Human Genome Research Institute, National Institutes of Health
  • 1 - 2

Datasets

Release 1.2